Publication: Human Bronchial Epithelial Cell Transcriptome Changes in Response to Serum from Patients with Different Status of Inflammation.
| dc.contributor.author | Sivaraman, Kokilavani | |
| dc.contributor.author | Liu, Bin | |
| dc.contributor.author | Martinez-Delgado, Beatriz | |
| dc.contributor.author | Held, Julia | |
| dc.contributor.author | Büttner, Manuela | |
| dc.contributor.author | Illig, Thomas | |
| dc.contributor.author | Volland, Sonja | |
| dc.contributor.author | Gomez-Mariano, Gema Maria | |
| dc.contributor.author | Jedicke, Nils | |
| dc.contributor.author | Yevsa, Tetyana | |
| dc.contributor.author | Welte, Tobias | |
| dc.contributor.author | DeLuca, David S | |
| dc.contributor.author | Wrenger, Sabine | |
| dc.contributor.author | Olejnicka, Beata | |
| dc.contributor.author | Janciauskiene, Sabina | |
| dc.contributor.funder | German Center for Lung Research (Alemania) | |
| dc.contributor.funder | National Science Centre (Polonia) | |
| dc.date.accessioned | 2026-11-04T12:03:43Z | |
| dc.date.available | 2026-11-04T12:03:43Z | |
| dc.date.issued | 2024-04 | |
| dc.description.abstract | Purpose: To investigate the transcriptome of human bronchial epithelial cells (HBEC) in response to serum from patients with different degrees of inflammation. Methods: Serum from 19 COVID-19 patients obtained from the Hannover Unified Biobank was used. At the time of sampling, 5 patients had a WHO Clinical Progression Scale (WHO-CPS) score of 9 (severe illness). The remaining 14 patients had a WHO-CPS of below 9 (range 1-7), and lower illness. Multiplex immunoassay was used to assess serum inflammatory markers. The culture medium of HBEC was supplemented with 2% of the patient's serum, and the cells were cultured at 37 °C, 5% CO2 for 18 h. Subsequently, cellular RNA was used for RNA-Seq. Results: Patients with scores below 9 had significantly lower albumin and serum levels of E-selectin, IL-8, and MCP-1 than patients with scores of 9. Principal component analysis based on 500 "core genes" of RNA-seq segregated cells into two subsets: exposed to serum from 4 (I) and 15 (II) patients. Cells from a subset (I) treated with serum from 4 patients with a score of 9 showed 5566 differentially expressed genes of which 2793 were up- and 2773 downregulated in comparison with cells of subset II treated with serum from 14 patients with scores between 1 and 7 and one with score = 9. In subset I cells, a higher expression of TLR4 and CXCL8 but a lower CDH1, ACE2, and HMOX1, and greater effects on genes involved in metabolic regulation, cytoskeletal organization, and kinase activity pathways were observed. Conclusion: This simple model could be useful to characterize patient serum and epithelial cell properties. | |
| dc.description.peerreviewed | Sí | |
| dc.description.sponsorship | This study was supported by COVAAT-TP1: “Alpha-1-Antitrypsin Zur COVID-19 Therapie,” ZW7-85152684 from the Enterprise Europe Network Niedersachsen (EEN) of the NBank, German Center for Lung Research, Grant number 82DZL002B1, Polish National Science Centre Grant 2015/17/B/NZ5/01370, and a research grant from ExcellGene SA (19400532). | |
| dc.format.number | 2 | |
| dc.format.page | 157 | |
| dc.format.volume | 202 | |
| dc.identifier.citation | Sivaraman, K., Liu, B., Martinez-Delgado, B. et al. Human Bronchial Epithelial Cell Transcriptome Changes in Response to Serum from Patients with Different Status of Inflammation. Lung 202, 157–170 (2024). https://doi.org/10.1007/s00408-024-00679-1. | |
| dc.identifier.doi | 10.1007/s00408-024-00679-1 | |
| dc.identifier.e-issn | 1432-1750 | |
| dc.identifier.journal | Lung | |
| dc.identifier.pubmedID | 38494528 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12105/27800 | |
| dc.language.iso | eng | |
| dc.publisher | Springer Nature | |
| dc.relation.projectID | info:eu-repo/grantAgreement/Enterprise Europe Network Niedersachsen (EEN) of the NBank//ZW7-85152684//Alpha-1-Antitrypsin Zur COVID-19 Therapie/COVAAT-TP1 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/German Center for Lung Research//82DZL002B1/// | |
| dc.relation.projectID | info:eu-repo/grantAgreement/Polish National Science Centre//2015%2F17%2FB%2FNZ5%2F01370/// | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ExcellGene//19400532/// | |
| dc.relation.publisherversion | https://doi.org/10.1007/s00408-024-00679-1 | |
| dc.repisalud.centro | ISCIII::Instituto de Investigación de Enfermedades Raras (IIER) | |
| dc.repisalud.institucion | ISCIII | |
| dc.rights.accessRights | open access | |
| dc.rights.license | Attribution 4.0 International License | |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
| dc.subject | Acute lung inflammation | |
| dc.subject | Chemokine/cytokine profile | |
| dc.subject | Gene expression | |
| dc.subject | Immune hyper-activation | |
| dc.subject | RNA-seq | |
| dc.subject.mesh | Biomarkers | |
| dc.subject.mesh | Epithelial Cells | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Inflammation | |
| dc.subject.mesh | Transcriptome | |
| dc.title | Human Bronchial Epithelial Cell Transcriptome Changes in Response to Serum from Patients with Different Status of Inflammation. | |
| dc.type | research article | |
| dc.type.hasVersion | VoR | |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | 1ddea53d-8bbc-4196-82a6-1f6b8ea3a92b | |
| relation.isAuthorOfPublication | d0ee7849-1683-4c6e-b977-2a93cf579641 | |
| relation.isAuthorOfPublication.latestForDiscovery | 1ddea53d-8bbc-4196-82a6-1f6b8ea3a92b | |
| relation.isFunderOfPublication | adefd933-e0fd-4eed-bd26-0b2334fa38a3 | |
| relation.isFunderOfPublication | 4ca70eff-1180-4b38-b7b3-228e4047432a | |
| relation.isFunderOfPublication.latestForDiscovery | adefd933-e0fd-4eed-bd26-0b2334fa38a3 | |
| relation.isPublisherOfPublication | b35c2080-c7d1-4e7c-95ea-1d4c7d394078 | |
| relation.isPublisherOfPublication.latestForDiscovery | b35c2080-c7d1-4e7c-95ea-1d4c7d394078 |


